Source: Benzinga

Guggenheim Partners: Guggenheim's Longstanding Pfizer Ties Tested Amid Starboard Battle

Guggenheim finds itself in the middle of a battle between Pfizer and Starboard Value as activist investors push for change amid declining stock performance and costly acquisitions. read more

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Mark R. Walter's photo - CEO of Guggenheim Partners

CEO

Mark R. Walter

CEO Approval Rating

90/100

Read more